Sankey It
Loading...
Pfizer Inc. Q2 FY2026 income statement | Sankey It
Sankey It · PFE
Pfizer Inc. Q2 FY2026 income statement
USD · quarter ended 2026-06-28
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Pfizer Inc. Q2 FY2026 income statement
Flow diagram with 6 nodes and 5 flows for Pfizer Inc. Q2 FY2026 income statement. Values: Revenue US$15B, Cost of Revenue US$4.1B, Gross Profit US$10.9B, Operating Expenses US$6.2B, Operating Income US$4.7B, Other Expense US$5.4B.
Revenue
US$15B
+3% Y/Y
Cost of Revenue
(US$4.1B)
-22% Y/Y
27% of revenue
Gross Profit
US$10.9B
+16% Y/Y
73% margin
Operating Expenses
(US$6.2B)
+7% Y/Y
41% of revenue
Operating Income
US$4.7B
+32% Y/Y
31% margin
Other Expense
(US$5.4B)
+909% Y/Y
Actual other expense was $5.4B
36% of revenue
Net / profit
Tax / cost
Copy link
Share on X
Open full screen